The Joint Task Force for the American Academy of Allergy Asthma Immunology and American College of Allergy Asthma Immunology and the American Gastroenterology Association recently published guidelines for the management of eosinophilic esophagitis (EoE). Because the guideline was published, dupilumab became the first and only medication to gain regulatory approval for the treatment of EoE. This expert opinion document provides a framework for how the clinician can consider using dupilumab in the treatment strategy for patients with EoE.
|Original language||English (US)|
|Number of pages||8|
|Journal||Annals of Allergy, Asthma and Immunology|
|State||Published - Mar 2023|
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
- Immunology and Allergy